Antiepileptic drug-related cognitive complaints in seizure-free children with epilepsy before and after drug discontinuation

Epilepsia

Volumn 39, Issue 10, 1998, Pages 1070-1074

  Aldenkamp, A P ^a,h   Alpherts, W C J ^b   Sandstedt, P ^c   Blennow, G ^d   Elmqvist, D ^d   Heijbel, J ^e   Nilsson, H L ^f   Tonnby, B ^g   Wahlander L ^f   Wosse, E ^f  

^a EPILEPSY CENTER KEMPENHAEGHE   (Netherlands)

^b Instituut voor Epilepsiebestrijding   (Netherlands)

^c Statens Senter Epilepsi ^*  (Norway)

^d LUND UNIVERSITY HOSPITAL   (Sweden)

^e UMEÅ UNIVERSITY HOSPITAL   (Sweden)

^f Pharmaceuticals Division   (Sweden)

^g HALMSTAD HOSPITAL   (Sweden)

^h Epilepsy Centre   (Netherlands)

Author keywords

Cognitive complaints; Cognitive function; Drug discontinuation; Quality of life; Seizure remission

Indexed keywords

ANTICONVULSIVE AGENT;

ADOLESCENT; ARTICLE; CHILD; CLINICAL TRIAL; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; EPILEPSY; HUMAN; MAJOR CLINICAL STUDY; MULTICENTER STUDY; PRIORITY JOURNAL; QUALITY OF LIFE; REMISSION;

ADOLESCENT; ANTICONVULSANTS; CHILD; COGNITION; COGNITION DISORDERS; EPILEPSY; FEMALE; FOLLOW-UP STUDIES; HEALTH STATUS; HUMANS; MALE; PERSONALITY INVENTORY; QUALITY OF LIFE; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 0031668520     PISSN: 00139580     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1528-1157.1998.tb01292.x     Document Type: Article

References (22)

1. Bergner M. Quality of life, health status, and clinical research. Med Care 1989;27(suppl):148-56.
2. Baker GA, Smith DF, Dewey M, Jacoby A, Chadwick DW. The initial development of a health-related quality of life model as an outcome measure in epilepsy. Epilepsy Res 1993;16:65-81.
3. Bowling A. Measuring health; a review of quality of life measurement scales. Philadelphia: Open University Press, Millton Kaynes, 1991.
4. Hermann BP. Quality of life in epilepsy. J Epilepsy 1992;5:153-65.
5. Trimble MR. Antiepileptic drugs, cognitive function, and behavior in children: evidence from recent studies. Epilepsia 1990;31(suppl 4):S30-4.
6. Deyo RA. Measuring functional outcomes in therapeutic trials for chronic disease. Controlled Clin Trials 1984;5:223-40.
7. Austin JK, Huster GA, Dunn DW, Risinger MW. Adolescents with active or inactive epilepsy or asthma: a comparison of quality of life. Epilepsia 1996;37:1228-38.
8. Aldenkamp AP, Alpherts WCJ, Blennow G, et al. Withdrawal of antiepileptic medication; effects on cognitive function in children - the results of the multicentre "Holmfrid" study. Neurology 1993;43:41-51.
9. Stein REK, Jessop DJ. Relationship between health status and psychosocial adjustment among children with chronic conditions. Pediatrics 1984;73:169-74.
10. Austin JK, Smith MS, Risinger MW, McNelis AM. Childhood epilepsy and asthma: comparison of quality of life. Epilepsia 1994; 35:608-15.
11. Aldenkamp AP. Psychosocial adaptation after normalisation of physical symptomatology; cognitive complaints of children and their parents after seizure remission - in search of the time-delay model. Int J Adolesc Med Health 1995;7:303-17.
12. Jacoby A, Baker GA, Steen N, Potts P, Chadwick DW. The clinical course of epilepsy and its psychological correlates: findings from a UK community study. Epilepsia 1996;37:148-61.
13. Tonnby B, Nilsson H, Aldenkamp AP, et al. Withdrawal of antiepileptic medication in children: correlation of cognitive function and plasma concentration-The multicentre Holmfrid Study. Epilepsy Res 1994;19:141-52.
14. Aldenkamp AP, Baker G, Pieters MSM, et al. The Neurotoxicity Scale; the validity of a patient-based scale, assessing neurotoxicity. Epilepsy Res 1995;20:229-39.
15. Aldenkamp AP, Baker GA. The Neurotoxicity Scale-II: results of a patient-based scale, assessing neurotoxicity in patients with epilepsy. Epilepsy Res 1997;27:165-73.
16. Aldenkamp AP, Alpherts WCJ, Blennow G, et al. Computerized assessment of cognitive function and quality of life. In: Dodson WE, Trimble MR, eds. Epilepsy and quality of life in epilepsy. New York: Raven Press. 1994:199-215.
17. Fallon T, Schwab-Stone M. Determinants of reliability in psychiatric surveys of children, aged 6-12. J Child Psychol Psychiatry 1994;8:1391-408.
18. Meador KJ, Loring DW. Cognitive effects of antiepileptic drugs. In: Devinsky O, Theodore W, eds. Epilepsy and behavior. New York: Wiley-Liss, 1991:151-70.
19. Achenbach TM, McConaugh H, Howell CT. Child/Adolescent behavioral and emotional problems: implications of cross-informant correlations for situational specificity. Psychol Bull 1987;101:213-32.
20. Carpay JA, Arts WFM, Vermeulen J, et al. Parent-completed scales for measuring seizure severity and severity of side-effects of antiepileptic drugs in childhood epilepsy: development and psychometric analysis. Epilepsy Res 1996;24:173-81.
21. Devinsky O, Cramer JA. Assessing quality of life in epilepsy: development of a new inventory. Epilepsia 1993;34(suppl 4): 00-00.
22. Editorial Comment. Doing better, feeling worse. Lancet 1990;336: 1037-8.